Abstract
Dr Vicente Vérez Bencomo is a world-renowned scientist who led the team that discovered and developed the Cuban Haemophilus influenzae type b (Hib) vaccine using a synthetic antigen - the first of its kind in the world. Educated in Cuba, Russia, and France, Dr Vérez has received numerous awards for his groundbreaking work, including the World Intellectual Property Organization's Gold Medal (2005), and the Cuban National Chemistry Award (2006). The Cuban Hib vaccine is undergoing evaluation by the World Health Organization for vaccination packages for use in the developing world. Dr Vérez has published widely in international scientific journals of impact and is the Cuban representative to the International Carbohydrates Organization and Senior Member of the Cuban Academy of Sciences. He is currently Director of the Center for the Study of Synthetic Antigens, under the aegis of the University of Havana's Chemistry Department. He sat down with MEDICC Review to talk about the global burden of Haemophilus influenzae type b, what motivates him as a scientist, how synthetic antigens might be applied to other vaccines, and what he is currently working on.
Highlights
Dr Vicente Vérez Bencomo is a world-renowned scientist who led the team that discovered and developed the Cuban Haemophilus influenzae type b (Hib) vaccine using a synthetic antigen – the first of its kind in the world
Dr Vérez has published widely in international scientific journals of impact and is the Cuban representative to the International Carbohydrates Organization and Senior Member of the Cuban Academy of Sciences. He is currently Director of the Center for the Study of Synthetic Antigens, under the aegis of the University of Havana’s Chemistry Department. He sat down with MEDICC Review to talk about the global burden of Haemophilus influenzae type b, what motivates him as a scientist, how synthetic antigens might be applied to other vaccines, and what he is currently working on
MEDICC Review (MR): But the price of this vaccine is still prohibitive for many public health systems
Summary
Dr Vicente Vérez Bencomo is a world-renowned scientist who led the team that discovered and developed the Cuban Haemophilus influenzae type b (Hib) vaccine using a synthetic antigen – the first of its kind in the world. He sat down with MEDICC Review to talk about the global burden of Haemophilus influenzae type b, what motivates him as a scientist, how synthetic antigens might be applied to other vaccines, and what he is currently working on. This is positive, it’s hopeful, since it’s another alternative for Haemophilus vaccine production; even if the money was available to vaccinate all the children in the world tomorrow, current production wouldn’t be enough to satisfy demand.
Sign-in/Register to view highlights & summary Sign-in/Register to access full text options 
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
